NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome Aneuploidy

@article{Wilson2012NSGCPG,
  title={NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome Aneuploidy},
  author={Katherine Lee Wilson and Jennifer L. Czerwinski and Jennifer M. Hoskovec and Sarah Jane Noblin and Cathy Sullivan and Andrea Harbison and MaryAnn Campion and K. Devary and Patricia L. Devers and Claire N Singletary},
  journal={Journal of Genetic Counseling},
  year={2012},
  volume={22},
  pages={4-15}
}
The BUN and FASTER studies, two prospective multicenter trials in the United States, validated the accuracy and detection rates of first and second trimester screening previously reported abroad. These studies, coupled with the 2007 release of the American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin that endorsed first trimester screening as an alternative to traditional second trimester multiple marker screening, led to an explosion of screening options available to… Expand
Aneuploidy Screening: The Ongoing Role of First-Trimester Ultrasound
TLDR
The landscape of prenatal aneuploidy screening has evolved from assessing a single parameter (maternal age) to incorporating a myriad of different ultrasound and serum markers, to the most current and direct method of analyzing fetal DNA within maternal circulation. Expand
Obstetrician and Gynecologist Utilization of the Noninvasive Prenatal Testing Expanded Option
TLDR
Based on these findings and the fluid landscape of prenatal screening, education, and reeducation of health care professionals is imperative to ensure responsible patient counseling, informed consent, and appropriate posttest management. Expand
Provider knowledge of non-invasive prenatal testing: a survey of obstetricians
TLDR
Results found that most participants demonstrated accurate knowledge of NIPT, but there was a discordance between clinical practice and current guidelines about offering NipT to the general obstetric population as 45.72% indicted not offering NIPt to low-risk patients. Expand
ACMG 2016 Update on Noninvasive Prenatal Testing for Fetal Aneuploidy: Implications for India
TLDR
NIPS has a greater detection rate than other screening methods and can be performed in place of conventional screening for Patau, Edwards, and Down syndromes, if the patient can afford the cost, and the ultrasound does not show a malformation that is not a part of aneuploidy. Expand
Recall Of Informed Consent For Prenatal Aneuploidy Screening
TLDR
The data support the importance of a thorough informed consent when discussing prenatal aneuploidy testing with patients and found significantly higher scores in women who were offered testing by genetic professionals, met with a genetic counselor in prior pregnancies, were 35-years or older, or were given the choice of both screening and diagnostic tests. Expand
An update on current prenatal testing options: first trimester and noninvasive prenatal testing.
TLDR
How these tests work; what to do with the results; and most importantly, how to support and communicate accurate information to women and families as they navigate through an increasingly complicated array of testing choices are discussed. Expand
ACOG approves new trisomy screen for high‐risk pregnancies
  • D. Levenson
  • Biology, Medicine
  • American journal of medical genetics. Part A
  • 2013
A new opinion from the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) says obstetricians can offer noninvasive prenatal testing (NIPT)Expand
Optimizing use of existing prenatal genetic tests: Screening and diagnostic testing for aneuploidy.
TLDR
This paper provides consensus recommendations from a workshop on the use of existing prenatal screening and diagnostic testing for aneuploidy on the introduction of new genetic tests into clinical practice. Expand
The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice
TLDR
Results indicate substantial variation in practice regarding which patients are offered NIPS and how counselors have incorporated this technology into existing screening routines, and the lack of consensus suggests that updated practice guidelines might benefit counselors. Expand
Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues
TLDR
Concerns regarding routinized testing, an unmet and increasing demand for genetic counseling services, social and economic disparities in access, impact on groups living with disabling conditions, and provider liability are addressed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 69 REFERENCES
First trimester diagnosis and screening for fetal aneuploidy
TLDR
First trimester screening between 11 and 14 weeks has been shown to be an effective and reliable screening test for Down syndrome and trisomy 18. Expand
Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011
TLDR
Prenatal screening has emphasized the detection of Down syndrome, but it is recognized that many of the screening tests have a variable potential to detect other aneuploidies, some other genetic disorders, specific fetal anatomic abnormalities and pregnancy complications such as preeclampsia. Expand
ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.
  • Medicine
  • Obstetrics and gynecology
  • 2007
TLDR
The purpose of this document is to present and evaluate the best available evidence for the use of ultrasonographic and serum markers for selected aneuploidy screening in pregnancy and offer practical recommendations for implementing Down syndrome screening in practice. Expand
First-trimester screening for trisomies 21 and 18
TLDR
A multicenter study of screening for trisomies 21 and 18 among patients with pregnancies between 74 and 97 days of gestation, based on maternal age, maternal levels of free β human chorionic gonadotropin and pregnancy-associated plasma protein A, and ultrasonographic measurement of fetal nuchal translucency identified 85.2 percent of the 61 cases of Down's syndrome. Expand
Invasive prenatal diagnostic techniques.
  • R. Wapner
  • Medicine
  • Seminars in perinatology
  • 2005
TLDR
Chorionic villus sampling has emerged as the only safe invasive prenatal diagnostic procedure prior to the 14(th) week of gestation and with equally experienced operators, CVS and second trimester amniocentesis have similar procedure induced miscarriage rates. Expand
Noninvasive Prenatal Testing/Noninvasive Prenatal Diagnosis: the Position of the National Society of Genetic Counselors
TLDR
Patients whose NIPT/NIPD results are abnormal, or who have other factors suggestive of a chromosome abnormality, should receive genetic counseling and be given the option of standard confirmatory diagnostic testing. Expand
Sequential Pathways of Testing After First-Trimester Screening for Trisomy 21
TLDR
The data demonstrate that a sequential screening program that provides patients with first-trimester results and offers the option for early invasive testing or additional serum screening in the second trimester can detect 98% of trisomy 21–affected pregnancies. Expand
First-trimester or second-trimester screening, or both, for down's syndrome
TLDR
First-trimester combined screening at 11 weeks of gestation is better than secondtrimester quadruple screening but at 13 weeks has results similar to second-tr pregnancy quadruple screened, except for the comparison between serum integrated screening and combined screening. Expand
First-trimester or second-trimester screening, or both, for Down's syndrome.
TLDR
First-trimester combined screening at 11 weeks of gestation is better than second- Trimester quadruple screening but at 13 weeks has results similar to second- trimester quadruples screening. Expand
Comparing Three Screening Strategies for Combining First- and Second-Trimester Down Syndrome Markers
TLDR
Integrated screening is the most efficient of the 3 strategies, but it is possible to select risk cutoffs for both sequential and contingent strategies that minimize losses in efficiency while maintaining early detection and early completion. Expand
...
1
2
3
4
5
...